Are HIV medicines reimbursed in the United Kingdom?
Of 28 verified HIV medicine records for the United Kingdom, 25 are available and reimbursed (89%), 1 are available but not reimbursed and 2 are not available. 10 further records are still under review.
Reimbursed 25
Apretude, Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey and 11 more
Available, not reimbursed 1
Yeytuo
Not available 2
Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)
Is PrEP available and reimbursed in the United Kingdom?
Yes. In SHAPE's review, PrEP is available and reimbursed in the United Kingdom.
PrEP recipients: 111,123 PrEP recipients (England, 2024; UKHSA)
PrEP is provided through publicly funded health services; delivery arrangements differ among the four UK nations. England reported 111,123 people accessing PrEP in 2024. [Source: https://www.gov.uk/government/statistics/hiv-annual-data/hiv-testing-prep-new-hiv-diagnoses-and-care-outcomes-for-people-accessing-hiv-services-2025-report] Lenacapavir for PrEP (Yeytuo) was approved by the MHRA in December 2025, but NICE draft guidance of 9 September 2026 does not recommend it for use in NHS England on cost-effectiveness grounds; the consultation closes on 30 September 2026 and the next committee meeting is scheduled for 3 November 2026. Injectable cabotegravir PrEP was recommended by NICE in October 2025 with a restricted indication for people who cannot use oral PrEP effectively. [Source: https://www.nice.org.uk/guidance/indevelopment/gid-ta11638]
Is DoxyPEP available in the United Kingdom?
Yes. In SHAPE's review, DoxyPEP is available and reimbursed in the United Kingdom.
England's sexual health services began targeted DoxyPEP provision in 2025 for eligible gay, bisexual and other men who have sex with men and transgender women; arrangements elsewhere in the UK may differ. [Source: https://www.gov.uk/government/publications/doxypep-monitoring-and-evaluation]
What is the policy on sexuality education in the United Kingdom?
SHAPE classifies the sexuality education framework in the United Kingdom as progressive. This describes the national policy framework, not how every school delivers it.
- National framework: Education policy is devolved. England has statutory Relationships, Sex and Health Education; Scotland, Wales and Northern Ireland use separate statutory or curricular frameworks with different content and opt-out rules.
- Interpretation: The status summarizes the verified policy framework; it does not guarantee uniform classroom delivery.
[Sources: https://www.gov.uk/government/publications/relationships-education-relationships-and-sex-education-rse-and-health-education/relationships-and-sex-education-rse-secondary ; https://www.unesco.org/gem-report/en/peer ; https://www.who.int/news-room/fact-sheets/detail/comprehensive-sexuality-education ; https://www.bzga-whocc.de/fileadmin/user_upload/Dokumente/BZgA_IPPFEN_ComprehensiveStudyReport_Online.pdf]
What are the rules on abortion and contraception in the United Kingdom?
SHAPE classifies family planning and abortion rights in the United Kingdom as progressive, combining abortion law and contraception policy.
- Abortion: In Great Britain, abortion is available up to 24 weeks under statutory grounds and provider authorization. Northern Ireland permits abortion on request through 12 weeks and on specified grounds later.
- Contraception: EPF's 2026 contraception-policy score is 95.8%; the atlas records broad national coverage.
- Interpretation: The status combines legal rules and national policy access; regional availability and individual eligibility may differ.
[Sources: https://abortion-policies.srhr.org/countries/ ; https://www.epfweb.org/sites/default/files/2026-02/CCInfoEU_A3_EN_2026_FEB22-HiRes.pdf]
Can migrants access healthcare in the United Kingdom?
SHAPE's editorial comparison places migrant healthcare access in the United Kingdom in the middle category (Warning). Entitlement: Residence-based secondary care; free primary and specified public-health care.
Provider type: NHS / public health services / NGO · International migrants (2024): 11,845,479
- Access rule: Primary care registration and specified public-health services are available without ordinary-residence status; HIV diagnosis and treatment are free, while many hospital services are residence based and chargeable.
- Main barriers: Charging rules, proof requests, fear of data use, language and uncertainty about exemptions can delay secondary care.
- Migration measure: UN DESA estimates 11,845,479 international migrants at mid-year 2024. This is a point-in-time stock, not the number of people who arrived during 2024. The estimate is based on the foreign-born population. Refugee, asylum-seeker or refugee-like population data are incorporated where indicated by UN DESA.
- Origin definition: The origin shares below use country or area of birth for foreign-born estimates and country of citizenship for foreign-citizen estimates. They do not establish a person's nationality, ethnicity, language, reason for migration, legal status, recent-arrival status or undocumented status.
- Measurement basis: Foreign-born population + refugee/asylum adjustments (UN DESA code B R)
- Evidence note: ECDC indicators use 2024 reports: the foreign-born share is calculated only among diagnoses with known origin; late diagnosis is the country-level share with CD4 <350 cells/µL and is not migrant-specific. Data Unavailable means no sufficiently interpretable value was published; a blank is not zero. The status is an editorial comparison of legal entitlement and practical access and does not apply equally to every migrant group.
Main origins: India (8.8%), Poland (7.6%), Romania (6%)
Selected HIV indicators: Foreign-born HIV Diagnoses (known origin, 2024): 82.1%; Late HIV Diagnosis (CD4 <350, 2024): 47.5%